Skip to main content
Researchers find inequities in cancer drug development
4/15/2019

New cancer therapies are expensive and have not been well tested among racial or ethnic minorities, raising concerns about affordability and whether the treatments provide comparable benefits across populations, two researchers from Brigham and Women's Hospital and Harvard Medical School write. Policies that promote health equity but do not stifle innovation include enforcing inclusive clinical trial enrollment protocols, designing reimbursement models based on proven efficacy and providing more money for outcomes research.

Full Story: